US Patent 7820206 Modulation of inflammation by hops fractions and derivatives
Patent 7820206 was granted and assigned to Metaproteomics on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+364 characters)
Article
Patent abstract
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Daniel O. Lukaczer0
DeAnn J. Liska0
Gary K. Darland0
Jeffrey S. Bland0
John G. Babish0
Matthew L. Tripp0
Robert Lerman0
Terrence Howell0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07820206 Modulation of inflammation by hops fractions and derivatives US Patent 7820206 Modulation of inflammation by hops fractions and derivatives
Infobox
Patent Number
07820206
Patent Number
7820206
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07820206 Modulation of inflammation by hops fractions and derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07820206
Date of patent
October 26, 2010
Patent application number
11344554
Date Filed
January 30, 2006
Patent primary examiner
Find more entities like US Patent 7820206 Modulation of inflammation by hops fractions and derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
